Jeffrey Janus, President, has a proven track record extending over eighteen years of creating profitable commercial cell based businesses and building corporate value as a result. Jeffrey was a founder of Lifeline Cell Technology, the keystone company to ISC's portfolio of cellular companies. He led in the development and commercialization of Clonetics Corporation and the Clonetics brand of human cell products for both research and clinical use. Clonetics is the leading brand of human-cell based products, well known for quality and innovation. That company was successfully sold in 1995 after ten consecutive years of profitable growth exceeding 20%. Mr. Janus foresaw the need for human cells in therapy and created businesses in the contract manufacturing of human cells and culture media and human cells for clinical use. He has organized businesses providing unique research products using living cells to conduct drug screening in the pharmaceutical industry, product testing in the consumer products industry and basic research at Universities and Government laboratories. Critical staff from Clonetics Corporation agreed to join Lifeline largely based on the success of working Mr. Janus in the past. Mr. Janus has a MBA and a Bachelor's degree in Biochemistry. E-Mail: JanusJ@lifelinecelltech.com. |